These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31018569)

  • 1. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
    Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosomal S6 kinase 2 is a key regulator in tumor promoter induced cell transformation.
    Cho YY; Yao K; Kim HG; Kang BS; Zheng D; Bode AM; Dong Z
    Cancer Res; 2007 Sep; 67(17):8104-12. PubMed ID: 17804722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of magnolin on ERKs inhibits Ras/ERKs/RSK2-signaling-mediated neoplastic cell transformation.
    Lee CJ; Lee HS; Ryu HW; Lee MH; Lee JY; Li Y; Dong Z; Lee HK; Oh SR; Cho YY
    Carcinogenesis; 2014 Feb; 35(2):432-41. PubMed ID: 24031026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel wiring of the AKT-RSK2 signaling pathway plays an essential role in cancer cell proliferation via a G
    Choi JS; Cho YY
    Biochem Biophys Res Commun; 2023 Jan; 642():66-74. PubMed ID: 36566564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eriodictyol inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation.
    Liu K; Cho YY; Yao K; Nadas J; Kim DJ; Cho EJ; Lee MH; Pugliese A; Zhang J; Bode AM; Dong Z; Dong Z
    J Biol Chem; 2011 Jan; 286(3):2057-66. PubMed ID: 21098035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor receptor-associated factor family protein 2 is a key mediator of the epidermal growth factor-induced ribosomal S6 kinase 2/cAMP-responsive element-binding protein/Fos protein signaling pathway.
    Peng C; Zhu F; Wen W; Yao K; Li S; Zykova T; Liu K; Li X; Ma WY; Bode AM; Dong Z
    J Biol Chem; 2012 Jul; 287(31):25881-92. PubMed ID: 22685297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
    Ahmad A; Zhang W; Wu M; Tan S; Zhu T
    Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epimagnolin targeting on an active pocket of mammalian target of rapamycin suppressed cell transformation and colony growth of lung cancer cells.
    Yoo SM; Lee CJ; Kang HC; Lee HS; Lee JY; Kim KD; Kim DJ; An HJ; Cho YY
    Mol Carcinog; 2019 Jul; 58(7):1221-1233. PubMed ID: 30887599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells.
    Stratford AL; Fry CJ; Desilets C; Davies AH; Cho YY; Li Y; Dong Z; Berquin IM; Roux PP; Dunn SE
    Breast Cancer Res; 2008; 10(6):R99. PubMed ID: 19036157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
    Kim KS; Kim J; Oh N; Kim MY; Park KS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RSK2-induced stress tolerance enhances cell survival signals mediated by inhibition of GSK3β activity.
    Lee CJ; Lee MH; Lee JY; Song JH; Lee HS; Cho YY
    Biochem Biophys Res Commun; 2013 Oct; 440(1):112-8. PubMed ID: 24055036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of RSK2 influences the biological activities of human osteosarcoma cells through inactivating AKT/mTOR signaling pathways.
    Qiu Q; Jiang J; Lin L; Cheng S; Xin D; Jiang W; Shen J; Hu Z
    Int J Oncol; 2016 Jun; 48(6):2508-20. PubMed ID: 27082640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal S6 kinase 2-forkhead box protein O4 signaling pathway plays an essential role in melanogenesis.
    Jeung D; Lee GE; Chen W; Byun J; Nam SB; Park YM; Lee HS; Kang HC; Lee JY; Kim KD; Hong YS; Lee CJ; Kim DJ; Cho YY
    Sci Rep; 2024 Apr; 14(1):9440. PubMed ID: 38658799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSK2 and its binding partners in cell proliferation, transformation and cancer development.
    Cho YY
    Arch Pharm Res; 2017 Mar; 40(3):291-303. PubMed ID: 28013489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1.
    Godeny MD; Sayeski PP
    Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1308-17. PubMed ID: 16723511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.
    Lee CJ; Lee MH; Yoo SM; Choi KI; Song JH; Jang JH; Oh SR; Ryu HW; Lee HS; Surh YJ; Cho YY
    BMC Cancer; 2015 Aug; 15():576. PubMed ID: 26253302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Targeting of ERKs/RSK2 Signaling Axis in Cancer Prevention.
    Yoo SM; Cho SJ; Cho YY
    J Cancer Prev; 2015 Sep; 20(3):165-71. PubMed ID: 26473154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential role of RSK2 in c-Fos-dependent osteosarcoma development.
    David JP; Mehic D; Bakiri L; Schilling AF; Mandic V; Priemel M; Idarraga MH; Reschke MO; Hoffmann O; Amling M; Wagner EF
    J Clin Invest; 2005 Mar; 115(3):664-72. PubMed ID: 15719069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of c-Fos gene transcription with malignant transformation of human bronchial epithelial cells.
    Lee HY; Chaudhary J; Walsh GL; Hong WK; Kurie JM
    Oncogene; 1998 Jun; 16(23):3039-46. PubMed ID: 9662337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.